Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
21/07/2026 07:31
BRIEF-Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study July 21 (Reuters) - Annexin Pharmaceuticals AB (publ) ANNX.ST:
UPDATES ON NINE PATIENTS TREATED IN NEXUS STUDY
NO LIMITING SAFETY OR TOLERABILITY FINDINGS REPORTED TO DATE
Source text: ID:nMFN8JSKrm
Further company coverage: ANNX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed